RAPP
NASDAQ HealthcareRapport Therapeutics, Inc. - Common Stock
Biotechnology
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company's lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. It also develops nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and migraine; and a9a10 nAChR for the treatment of hearing/vestibular disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.
๐ Market Data
| Price | $32.19 |
|---|---|
| Volume | 166,835 |
| Market Cap | 1.55B |
| Beta | 1.030 |
| RSI (14-Day) | 7.4 Oversold |
| 200-Day MA | $35.60 |
| 50-Day MA | $44.43 |
| 52-Week High | $52.93 |
| 52-Week Low | $23.75 |
| Forward P/E | -6.16 |
| Price / Book | 3.65 |
๐ฏ Investment Strategy Scores
RAPP scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (88/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Over-Hyped (1/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find RAPP in your text
Paste any article, transcript, or post โ the tool will extract RAPP and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-09-24.